CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-09 | Opaleye, L.P. 10% owner | Grant or award | +1,426,234 | $7.01 | $10.0M | 2,208,472 |
| 2019-11-12 | Haines Timothy Former Director and 10% Owner | Conversion | +126,645 | $0.99 | $126K | 2,144,517 |
| 2019-11-12 | Haines Timothy Former Director and 10% Owner | Conversion · Series A Convertible Preferred Stock | −126 | 2,400 | ||
| 2019-11-12 | Abingworth LLP Former 10% Owner | Conversion | +126,645 | $0.99 | $126K | 2,144,517 |
| 2019-11-12 | Abingworth LLP Former 10% Owner | Conversion · Series A Convertible Preferred Stock | −126 | 2,400 | ||
| 2019-11-08 | Freund John Gordon Director | Conversion | +703,588 | $0.99 | $700K | 2,175,882 |
| 2019-11-08 | Freund John Gordon Director | Conversion · Series A Convertible Preferred Stock | −700 | 354 | ||
| 2019-03-15 | Burke Steven Keith SVP and Chief Medical Officer | Gift | −7,334 | 116,584 | ||
| 2019-03-15 | Burke Steven Keith SVP and Chief Medical Officer | Gift | −7,333 | 109,251 | ||
| 2019-03-15 | Burke Steven Keith SVP and Chief Medical Officer | Gift | −7,333 | 101,917 | ||
| 2019-03-15 | Burke Steven Keith SVP and Chief Medical Officer | Gift | +7,333 | 18,999 | ||
| 2019-03-15 | Burke Steven Keith SVP and Chief Medical Officer | Gift | +7,333 | 26,332 | ||
| 2019-01-31 | NOYES TIMOTHY P President and CEO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2019-01-18 | Gottlieb Daniel Philip VP Corporate Development | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-01-18 | Toner E. Scott Senior VP of Commercial | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-01-18 | Kowalsky Matthew Paul VP, Legal and Secretary | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-01-18 | Hartman Bradley J VP, People | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2019-01-18 | Eldridge, George Arthur Sr VP, CFO, Treasr, Asst Secy | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2019-01-18 | Burke Steven Keith SVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2018-12-31 | Toner E. Scott Senior VP of Commercial | Grant or award | +4,117 | $1.93 | $8K | 23,357 |
Page 18 of 24 · 473 trades